STOCK TITAN

If You Invested in DBV TECHNOLOGIES SA (DBVTF)

Healthcare · Biotechnology · OTC
Looking for the current price? See the DBVTF quote & overview
$1,000 invested 1 Year Ago
$888
-11.2% total -37.7% CAGR
Bought on Jan 27, 2026 at $4.80
$1,000 invested 5 Years Ago
N/A
Trading since 2024-10-29

What $1,000 or $10,000 in DBVTF Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Oct 29, 2024
$1,000 $888 -11% $5,421 +442%
$10,000 $8,876 -11% $54,205 +442%

Based on real historical closing prices, dividend- and split-adjusted, through 2026-04-29. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for DBVTF

$1,000 Investment Over Time

DBVTF vs S&P 500

Year-by-Year Returns

DBVTF annual performance
Year Start Price End Price Annual Return Cumulative
2024 $0.7859 $0.7859 +0.0% +0.0%
2025 $0.1945 $0.0001 -99.9% -100.0%
2026 $4.80 $4.26 -11.2% +442.1%

About DBV TECHNOLOGIES SA

Healthcare · OTC

DBV Technologies S.A. (DBVTF) is a French company whose securities are associated with American Depositary Shares (ADSs) trading under the symbol DBVT on The Nasdaq Stock Market LLC. Each ADS represents five ordinary shares with a nominal value of €0.10 per share. The company is organized in France and is registered with the U.S. Securities and Exchange Commission in connection with its Nasdaq listing.

According to its SEC filings, DBV Technologies S.A. has ordinary shares and American Depositary Shares registered under Section 12(b) of the Securities Exchange Act of 1934. The ADSs trade on The Nasdaq Stock Market LLC, while the ordinary shares are noted as being listed in connection with that ADS program. The company is identified in SEC records with Commission File Number 001-36697 and is based in France.

The available regulatory information highlights DBV Technologies S.A.’s status as a foreign private issuer with securities registered in the United States. Its filings include current reports on Form 8-K that disclose material corporate events, such as changes in the composition of its Board of Directors. These disclosures provide investors with insight into corporate governance developments and other significant matters affecting the company.

In a Form 8-K filed with the SEC, DBV Technologies S.A. reported the resignation of a member of its Board of Directors and of the compensation committee of the Board. The filing states that the resignation was effective immediately and that it was not the result of any dispute or disagreement with the company or the Board. The company also issued a press release regarding this event, which was furnished as an exhibit to the filing.

Because only limited descriptive information is available in the provided sources, public investors primarily rely on DBV Technologies S.A.’s SEC filings to understand its corporate structure, the nature of its listed securities, and key governance changes. The company’s presence on The Nasdaq Stock Market LLC through its ADSs indicates that it has chosen to access U.S. capital markets and comply with associated reporting obligations.

Stock listing and securities

DBV Technologies S.A. has ordinary shares with a nominal value of €0.10 per share and American Depositary Shares, each ADS representing five ordinary shares. The ADSs trade under the symbol DBVT on The Nasdaq Stock Market LLC. The ordinary shares are noted in SEC disclosures as being listed in connection with the registration of the ADSs on Nasdaq. This structure allows U.S. investors to gain exposure to the company’s equity through ADSs while the underlying ordinary shares remain issued by the French entity.

Regulatory reporting and governance

As reflected in its Form 8-K filing, DBV Technologies S.A. reports material corporate events to the SEC, including changes involving directors and certain officers. In one such filing, the company disclosed the resignation of a Board member and compensation committee member, clarifying that the resignation did not arise from any dispute or disagreement with the company or its Board. The company furnished a related press release as an exhibit to that report.

These filings illustrate how DBV Technologies S.A. communicates governance changes to the market. Investors can monitor such reports to follow developments in the composition of the Board of Directors and to understand how the company addresses its disclosure obligations under U.S. securities laws.

Use of SEC filings for research

Given the limited descriptive information in the provided data, DBV Technologies S.A.’s SEC filings are a primary reference for understanding its listed securities, regulatory status, and key corporate events. Filings such as Form 8-K identify the company’s jurisdiction (France), its Commission File Number, the nature of its listed securities, and specific events the company chooses or is required to disclose.

Investors researching DBV Technologies S.A. can review these documents to see how the company describes its securities, how it complies with Nasdaq-related reporting, and how it handles Board-level changes. Over time, the sequence of filings can provide a historical record of significant events affecting the company.

Frequently asked questions about DBV Technologies S.A. (DBVTF)

  • What is DBV Technologies S.A.?

    DBV Technologies S.A. is a company organized in France whose securities include ordinary shares and American Depositary Shares registered with the U.S. Securities and Exchange Commission. Its ADSs are listed on The Nasdaq Stock Market LLC under the symbol DBVT, with each ADS representing five ordinary shares with a nominal value of €0.10 per share.

  • How is DBV Technologies S.A. related to the DBVTF symbol?

    The information provided identifies DBV Technologies S.A. as the underlying company, with American Depositary Shares trading on The Nasdaq Stock Market LLC under the symbol DBVT. The DBVTF symbol refers to the company in other trading contexts, while SEC filings specifically reference the Nasdaq-listed ADSs.

  • On which exchange are DBV Technologies S.A.’s securities listed?

    According to its SEC Form 8-K, American Depositary Shares of DBV Technologies S.A., each representing five ordinary shares, are listed on The Nasdaq Stock Market LLC under the trading symbol DBVT. The ordinary shares are noted as being listed in connection with the registration of the ADSs on Nasdaq.

  • What types of securities does DBV Technologies S.A. have registered with the SEC?

    DBV Technologies S.A. has ordinary shares with a nominal value of €0.10 per share and American Depositary Shares, each representing five ordinary shares, registered pursuant to Section 12(b) of the Securities Exchange Act of 1934. The ADSs trade on The Nasdaq Stock Market LLC.

  • What kind of information has DBV Technologies S.A. reported on Form 8-K?

    In the provided Form 8-K, DBV Technologies S.A. reported a material event involving the resignation of a member of its Board of Directors and of the compensation committee of the Board. The filing notes that the resignation was effective immediately and that it was not due to any dispute or disagreement with the company or the Board.

  • Why did a DBV Technologies S.A. Board member resign, according to the SEC filing?

    The Form 8-K states that the Board member’s resignation from the Board of Directors and the compensation committee was not the result of any dispute or disagreement with DBV Technologies S.A. or its Board. The filing does not provide additional reasons beyond that clarification.

  • How does DBV Technologies S.A. communicate Board changes to investors?

    DBV Technologies S.A. communicates Board changes through SEC filings such as Form 8-K. In the referenced filing, the company disclosed the resignation of a director and furnished a related press release as an exhibit, providing public information about the governance change.

  • Where is DBV Technologies S.A. based?

    The Form 8-K identifies DBV Technologies S.A. as a company organized in France, and the filing lists a location in Châtillon, France, as part of the company’s address information.

Market Cap
$1.3B
Current Price
$4.26
EPS
$-1.05
Revenue
$0.0B
Net Margin
-2607.3%
View full DBVTF overview

Frequently Asked Questions

DBV TECHNOLOGIES SA investment returns

How much would $1,000 invested in DBV TECHNOLOGIES SA be worth today?

If you invested $1,000 in DBV TECHNOLOGIES SA (DBVTF) 1 years ago on 2026-01-27, your investment would be worth $888 as of 2026-04-29, representing a -11.2% total return, growing at a compounded rate of -37.7% per year (CAGR).

Has DBV TECHNOLOGIES SA outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare DBVTF performance over available time periods.

What is DBV TECHNOLOGIES SA's average annual return?

The compound annual growth rate (CAGR) of DBVTF over the past 1 years is -37.7%, growing at a compounded rate each year. Individual years vary significantly — DBVTF's best recent year was 2024 (+0.0%) and worst was 2025 (-99.9%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.